During the past decade, Hopital Neuchatelois conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hopital Neuchatelois" #1 sponsor was "University Hospital Inselspital, Berne" with 3 trials, followed by "AbbVie" with 1 trials sponsored, "Cyril Pellaton" with 1 trials sponsored, "Pediatric Clinical Research Platform" with 1 trials sponsored and "Vertex Pharmaceuticals Incorporated" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Neuchatelois" #1 collaborator was "University of Bern" with 2 trials as a collaborator, "Aktiia SA" with 1 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "Fribourg Hospital, Fribourg, Switzerland" with 1 trials as a collaborator and "Neuchâtel Hospital, Neuchâtel, Switzerland" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Hopital Neuchatelois" are "Blood Pressure" (1 trials), "Chronic Hepatitis C Virus (HCV)" (1 trials), "Cystic Fibrosis" (1 trials), "Hypertension" (1 trials) and "Ischaemic Stroke" (1 trials). Many other conditions were trialed in "Hopital Neuchatelois" in a lesser frequency.

Most popular intervention types in "Hopital Neuchatelois" are "Device" (2 trials), "Drug" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Aktiia.product" (1 trials), "Conventional Method / PedAMINES™" (1 trials), "ELX/TEZ/IVA" (1 trials), "Early treatment with Rivaroxaban (Xarelto®), Dabigatran (Pradaxa®), Apixaban (Eliquis®) or Edoxaban (Lixiana®)" (1 trials) and "IVA" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Neuchatelois" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Hopital Neuchatelois". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Hopital Neuchatelois, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Neuchatelois, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".